United Kingdom · Question · Written question
UIN 179820
Breast Cancer: Drugs
Introduced
14 April 2023
Last action
20 April 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 April 2023
Summary
To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that the National Institute for Clinical Excellence and the Scottish Medicines Consortium collaborate effectively on drug approvals for metastatic breast cancer
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 April 2023
Written question
To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that the National Institute for Clinical Excellence and the Scottish Medicines Consortium collaborate effectively on drug approvals for metastatic breast cancer
Source: Commons
20 April 2023
Answer
The National Institute for Health and Care Excellence (NICE) is committed to publishing draft recommendations on all newly licensed treatments around the time of licensing in England and works closely with the Medicines and Healthcare products Regulatory ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-04-14/179820
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1609687
- uk · wq-1609687 · source updated 20 April 2023